T-Knife Therapeutics is a private biotechnology company. It has raised $110 million across 1 recorded round; the latest was an $110 million Series B in Aug 2021.
PMV mark · valuation
—
Oct 2026
Priced at
—
Total raised
$110.0M
Last round
Later Stage VC (Series B)
Aug 2021
Team — not yet on record
No current team members for T-Knife Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of T-Knife Therapeutics with a free account
·Watch T-Knife Therapeutics: the Monday email on marks, rounds and moves
